Could Roche's Ocrevus be doing more harm than good in women w/PPMS? (BritMedJrl) on: April 16, 2026, 09:12:30 pm #1 From the British Medical Journal (April 15, 2026)--"Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS?"https://www.bmj.com/content/393/bmj Last Edit: April 17, 2026, 06:58:53 am by agate Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
